Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504738
Status:
COMPLETED
Last Update Posted:
2015-04-21
First Post:
2007-07-19
Brief Title:
Lung Disease Collection Qatar Evaluation of the Lungs of Individuals With Lung Disease
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
Evaluation of the Lungs of Individuals With Lung Disease With Segmental Bronchopulmonary Lung Lavage Bronchial Brushing and Bronchial Wall Biopsy Qatar
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Q-LD
Brief Summary:
The purpose of this protocol is to obtain biologic samples from the blood and lungs from patients with lung diseases in order to study the causes and indications of these disorders learn how these lung disease manifest and progress and how the lung disease can be treated
Detailed Description:
The lung diseases are disorders associated with functional andor structural derangements to the alveolar structures airways pulmonary blood vessels pleura andor mediastinum The purpose of this protocol is to obtain biologic materials from the blood and lungs from these patients in order to 1 develop an understanding of the etiology and pathogenesis of these disorders and 2 identify individuals who will be suitable candidates for other protocols such as those involving investigational new drugs As such this protocol is part of the infrastructure for all of our human lung-related studies such as genomicgene expression studies of airway epithelium and alveolar macrophages in all individuals with chronic obstructive lung disease COPD asthma bronchogenic carcinoma and pulmonary fibrosis compared to normal non-smokers and smokers and studies of mediators in bronchoalveolar lavage fluid
This protocol to be carried out at Weill Cornell Medical College - Qatar and Hamad Medical Corporation Qatar parallels a similar approved protocol IRB 0005004440 entitled Evaluation of the Lungs of Individuals with Lung Disease with Segmental Bronchopulmonary Lung Lavage Bronchial Brushing and Bronchial Wall Biopsy ongoing at Weill Cornell Medical College - New York
This protocol to be carried out at Weill Cornell Medical College - Qatar and Hamad Medical Corporation Qatar parallels a similar approved protocol IRB 0005004440 entitled Evaluation of the Lungs of Individuals with Lung Disease with Segmental Bronchopulmonary Lung Lavage Bronchial Brushing and Bronchial Wall Biopsy ongoing at Weill Cornell Medical College - New York
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HMC RC3922006 | OTHER | Hamad Medical Corporation | None |